SLXP

Salix Pharmaceuticals, Ltd. News Headlines

$139.65
*  
0.29
0.21%
Get SLXP Alerts
*Delayed - data as of Oct. 30, 2014 9:32 ET  -  Find a broker to begin trading SLXP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SLXP Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Synergy Pharma presents plecanatide IBS-C clinical trial results
10/21/2014 10:11:00 AM - Seeking Alpha


Bloomberg: Actavis Among Final-stage Bidders For Omega Pharmaceuticals
10/20/2014 10:49:00 PM - RTT News


Medical Properties To Buy 40 Rehabilitation Hospitals In Germany For $900 Mln
10/20/2014 10:48:00 PM - RTT News


Making Money With Charles Payne: 10/17/14
10/17/2014 6:00:00 PM - Fox Business


Sector Update: Health Care Stock Retreat; Shire Tumbles After Abbvie Reconsiders $55 Bln Inversion Deal
10/15/2014 1:34:15 PM - MT Newswires


Sector Update: Health Care
10/15/2014 1:24:04 PM - MT Newswires


These companies love seeing a stronger dollar
10/13/2014 11:00:00 AM - InvestorsObserver


Allergan Raises Outlook amidst Valeant Takeover Attempts - Analyst Blog
10/10/2014 5:20:00 PM - Zacks.com


Salix's Rectal Foam Uceris Receives Final FDA Approval - Analyst Blog
10/9/2014 6:30:00 PM - Zacks.com


Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?
10/9/2014 3:52:30 PM - Motley Fool


Salix Pharma: FDA Approves UCERIS Rectal Foam - Quick Facts
10/8/2014 8:40:00 AM - RTT News


Valeant To Raise Allergan Bid By $15 A Share: Reports
10/7/2014 8:04:00 PM - RTT News


Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene
10/7/2014 6:33:00 PM - Investor's Business Daily


Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog
10/7/2014 5:05:00 PM - Zacks.com


ACT Opens Wallet, ADHD Craters, CMRX Focuses On Ebola, REGN Gets FDA Nod
10/7/2014 4:37:00 AM - RTT News


Allergan has a smooth, youthful look
10/6/2014 11:00:00 AM - InvestorsObserver


Actavis To Acquire Durata Therapeutics In $675 Mln Deal
10/6/2014 9:01:00 AM - RTT News


Sector Update: Huge Rebound for Health Care Sector; Salix Pharmaceutics Higher After Dropping Potential Merger Partner
10/3/2014 1:07:53 PM - MT Newswires


Why Salix Pharmaceuticals (SLXP) Stock Is Gaining Today
10/3/2014 12:59:00 PM - TheStreet


Sector Update: Health Care
10/3/2014 12:47:40 PM - MT Newswires


Swiss Stocks Rise But UBS Slides On Fears Of Massive French Fine
10/3/2014 12:08:00 PM - RTT News


Salix Seen as Target After Scrapping Tax Inversion Cosmo Purchase
10/3/2014 12:07:00 PM - TheStreet


Why Salix Pharmaceuticals (SLXP) Stock Is Surging Today
10/3/2014 8:07:00 AM - TheStreet


October 3 Premarket Briefing: 10 Things You Should Know
10/3/2014 6:48:00 AM - TheStreet


European Stocks Are Higher Despite Downbeat Economic Data
10/3/2014 6:33:00 AM - TheStreet